LIBERATOR MEDICAL HLDGS INC (LBMH) Fundamental Analysis & Valuation

NYSEARCA:LBMH • US53012L1089

Current stock price

3.35
0 (0%)
Last:

This LBMH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

No Fundamental Analysis report for LBMH not available.

LBMH Fundamentals: All Metrics, Ratios and Statistics

LIBERATOR MEDICAL HLDGS INC

NYSEARCA:LBMH (1/21/2016, 7:54:37 PM)

3.35

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners26.71%
Inst Owner ChangeN/A
Ins Owners23.69%
Ins Owner Change0%
Market Cap179.09M
Revenue(TTM)81
Net Income(TTM)N/A
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.39%
Yearly Dividend0.08
Dividend Growth(5Y)0%
DP94.94%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.33
Fwd PE 22.33
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.32
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.15
EY4.48%
EPS(NY)0.15
Fwd EY4.48%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpS0.63
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.84
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 12.51%
ROE 21.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 100.57%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.42
Altman-Z 5.61
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5Y26.67%
EPS Q2Q%-100%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

LIBERATOR MEDICAL HLDGS INC / LBMH Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LIBERATOR MEDICAL HLDGS INC (LBMH) stock?

ChartMill assigns a fundamental rating of null / 10 to LBMH.


Can you provide the valuation status for LIBERATOR MEDICAL HLDGS INC?

ChartMill assigns a valuation rating of null / 10 to LIBERATOR MEDICAL HLDGS INC (LBMH). This can be considered as Overvalued.


How profitable is LIBERATOR MEDICAL HLDGS INC (LBMH) stock?

LIBERATOR MEDICAL HLDGS INC (LBMH) has a profitability rating of null / 10.


What are the PE and PB ratios of LIBERATOR MEDICAL HLDGS INC (LBMH) stock?

The Price/Earnings (PE) ratio for LIBERATOR MEDICAL HLDGS INC (LBMH) is 22.33 and the Price/Book (PB) ratio is 5.32.